CJC-1295 With DAC 2mg

Description

CJC-1295 With DAC 2mg For Sale — Long-Acting GHRH Peptide

CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue engineered for extended plasma half-life through albumin binding. The 2mg vial is ideal for shorter research protocols or initial dose-finding studies before scaling to larger volumes.

Research Profile

CJC-1295 with DAC sustains GH and IGF-1 elevation for approximately 6–8 days per injection. This extended profile makes it valuable for studying chronic GH secretagogue effects and comparing sustained versus pulsatile GH release in body composition and metabolic research. The 2mg format provides a cost-effective entry point for CJC with DAC research programs.

Product Specifications

• Compound: CJC-1295 with DAC (Modified GHRH analogue)
• Amount: 2mg per vial
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder
• Testing: Third-party Certificate of Analysis available
• Storage: -20°C lyophilized; 4°C after reconstitution, use within 28 days
• For laboratory and research use only — not for human consumption

For research and laboratory use only. Not intended for human consumption.